Daniel Kaufman files Schedule 13G — Abeona (NASDAQ: ABEO) 5.16% stake

Rhea-AI Filing Summary

Abeona Therapeutics Inc. ownership filing reports that Daniel Kaufman beneficially owns 2,943,629 shares of Common Stock, representing 5.16% of the class. The filing lists Kaufman’s sole voting and dispositive power over these shares.

The Schedule 13G is signed by Daniel Kaufman on 03/27/2026 and discloses his address and CUSIP 00289Y206.

Insights

Governance Analyst

Holds a passive, disclosed stake just above 5% threshold.

The filing shows 2,943,629 shares, or 5.16%, held with sole voting and dispositive power. As a Schedule 13G disclosure, this typically indicates passive ownership rather than an active acquisition intent.

Beneficial ownership at this level may trigger monitoring by the company and other market participants; subsequent filings could update holdings if the position changes.

Compliance Counsel

Form type and signatures align with passive investor reporting requirements.

The form identifies the filer, his citizenship, address, and CUSIP 00289Y206, and is signed on 03/27/2026. The reporting of sole voting and dispositive power is explicit in Item 4.

No additional qualifiers or plans (e.g., acquisition intent) are stated in the excerpt; future disclosures would show any material change.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

ABEONA THERAPEUTICS INC.

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)

00289Y206

(CUSIP Number)

03/26/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 00289Y206

1

Names of Reporting Persons

Daniel Kaufman

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,943,629.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,943,629.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,943,629.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.16 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ABEONA THERAPEUTICS INC.
(b)	Address of issuer's principal executive offices: 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND OH 44103
Item 2.
(a)	Name of person filing: Daniel Kaufman
(b)	Address or principal business office or, if none, residence: 2158 Park Boulevard, San Juan, Puerto Rico, 00913
(c)	Citizenship: United States
(d)	Title of class of securities: Common Stock, $0.01 par value
(e)	CUSIP Number(s): 00289Y206
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2,943,629
(b)	Percent of class: 5.16%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2,943,629
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 2,943,629
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Daniel Kaufman

Signature:	/s/ Daniel Kaufman
Name/Title:	Daniel Kaufman, Individual Investor
Date:	03/27/2026

Exhibit Information

None

FAQ

What does Daniel Kaufman's Schedule 13G filing for ABEO mean?

It means Kaufman reports beneficial ownership of 2,943,629 shares, equal to 5.16% of Abeona's common stock. The filing lists sole voting and dispositive power and is signed on 03/27/2026, indicating passive disclosure under Schedule 13G.

Does the Schedule 13G indicate Kaufman will control Abeona (ABEO)?

No. The filing documents beneficial ownership and sole voting power over his shares, but Schedule 13G generally indicates passive investment rather than a control intent. The excerpt contains no language asserting takeover or active control steps.

How much of Abeona common stock does Kaufman own as reported?

The filing reports Kaufman beneficially owns 2,943,629 shares, representing 5.16% of the class. Item 4 lists both sole voting power and sole dispositive power for the same share count.

When was Kaufman's beneficial ownership signed and filed for ABEO?

The signature date on the excerpt is 03/27/2026. The cover header shows a related date of 03/26/2026, and the form is signed by Daniel Kaufman as an individual investor.